Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Change in Receivables (2010 - 2026)

Omeros (OMER) posted Change in Receivables of $1.1 million for Q1 2026, down 72.19% sequentially from $4.0 million in Q4 2025, and up 268.17% YoY from $302845.1 in Q1 2025.

Analysis

Omeros (OMER) Change in Receivables (2010 - 2026) Analysis & Trends

Omeros has reported Change in Receivables for 17 years, with the latest figure at $1.1 million in Q1 2026.

  • Quarterly Change in Receivables rose 268.17% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 975.62% YoY) and the FY2025 annual result came in at $3.2 million, up 990.2% from the prior year.
  • Change in Receivables fell to $1.1 million in Q1 2026 per OMER's latest filing, from $4.0 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $199.4 million in Q4 2022 and troughed at -$203.2 million in Q1 2023.
  • A 5-year average of -$1.5 million and a median of -$454000.0 in 2024 frame the typical range for Change in Receivables.
  • The sharpest annual moves came in 2022 and 2023: Change in Receivables jumped 4583.27% in 2022, then sank 827.8% in 2023.
  • Over 5 years, Change in Receivables stood at $199.4 million in 2022, then sank by 99.39% to $1.2 million in 2023, then increased by 17.65% to $1.4 million in 2024, then jumped by 179.76% to $4.0 million in 2025, then plunged by 72.19% to $1.1 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods registered $1.1 million, $4.0 million, and $632000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -53.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 117.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 31.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 37.16 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn 9.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.27 Mn
Mar 31, 2026 1.12 Mn
Dec 31, 2025 4.01 Mn
Sep 30, 2025 632,000.00
Jun 30, 2025 -800,000.00
Mar 31, 2025 -663,000.00
Dec 31, 2024 1.43 Mn
Sep 30, 2024 -1.77 Mn
Jun 30, 2024 438,000.00
Mar 31, 2024 -454,000.00
Dec 31, 2023 1.22 Mn
Sep 30, 2023 -4.31 Mn
Jun 30, 2023 1.16 Mn
Mar 31, 2023 -203.19 Mn
Dec 31, 2022 199.37 Mn
Sep 30, 2022 -625,000.00
Jun 30, 2022 -1.78 Mn
Mar 31, 2022 -21.90 Mn
Dec 31, 2021 4.26 Mn
Sep 30, 2021 2.06 Mn